Skip to content

Unilever Faces New Attack From Investors Over Health Credentials

Fresh off the collapse of its effort to buy GlaxoSmithKline Plc’s consumer division, Unilever Plc has again found itself the target of investor criticism, this time over what asset managers and doctors say is its failure to promote healthy eating.

A resolution co-filed by a group of investors with $215 billion in assets under management, as well as medical professionals and health campaigners, called on the consumer behemoth to set targets to increase the share of healthy food products it sells.